Skip to main content

Young Hye Ko

Sungkyunkwan University · 医学

研究室紹介

Professor Young Hye Ko's research lab specializes in hematological malignancies, with a primary focus on the molecular pathology, clinical characteristics, and treatment outcomes of various lymphomas, including plasmablastic lymphoma, marginal zone B-cell lymphoma, NK/T-cell lymphoma, and angioimmunoblastic T-cell lymphoma. The lab integrates clinical oncology with molecular and imaging techniques, utilizing proteomics, immunohistochemistry, and advanced radiological modalities such as multidetector CT and MRI to improve diagnosis, risk stratification, and therapeutic strategies. Their work also explores the role of stress proteins like Hsp27 in vascular pathology, linking molecular mechanisms to disease progression in atherosclerosis.

lymphomahematologic malignanciescardiac tumorsproteomicsclinical oncology

Research Overview

Papers
85
Total Citations
741
Papers (5y)
7
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
7total
2015
2016
2017
2018
2020
Citations per year (5y)
51total
20152016201720182020

Selected Papers

15
1
Article|153 citations·2006
Expression of Heat Shock Protein 27 in Human Atherosclerotic Plaques and Increased Plasma Level of Heat Shock Protein 27 in Patients With Acute Coronary Syndrome
Haing Kee Park, Eui-Chul Park, Sung Won Bae, Mi Young Park, Seon Woon Kim, Hwan Soo Yoo, Munkhtsetseg Tudev, Young Hye Ko, Yoon-Ho Choi, Sungjoo Kim, Dong‐Ik Kim, Young Wook Kim
SJR Q1Circulation

BACKGROUND: We intended to identify proteins that are differentially expressed in human atherosclerotic plaques. METHODS AND RESULTS: Comparative 2-dimensional electrophoretic analysis on carotid atherosclerotic endarterectomy specimens (n = 10) revealed that heat shock protein 27 (Hsp27) expression was significantly increased in the nearby normal-appearing area compared with the plaque core area from the same vessel specimen, which was further confirmed by Western blot analysis. The Hsp27 expre

Molecular BiologyBiochemistry, Genetics and Molecular Biology
2
Article|59 citations·2009
Human immunodeficiency virus-negative plasmablastic lymphoma in Korea
Ji Eun Kim, Young A Kim, Wook Youn Kim, Chul Woo Kim, Young Hye Ko, Geon Kook Lee, Suk‐Jin Choi, Yoon Kyung Jeon
SJR Q2Leukemia & lymphoma/Leukemia and lymphoma

Plasmablastic lymphoma (PBL) is very rare, and predominantly occurs in Human immunodeficiency virus (HIV)-positive individuals. It shows a strong affinity for the oral cavity and for the Epstein-Barr virus (EBV) positive. We investigated the clinicopathologic characteristics of six cases of PBL in Koreans. All patients were HIV-negative and without underlying immunodeficiency. The age distribution was bimodal, and four patients were older than 60 years. Male predominance was observed with male t

OncologyMedicine
3
Article|44 citations·2006
Nodal marginal zone B-cell lymphoma: analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma
Sung Yong Oh, Baek‐Yeol Ryoo, Won Gu Kim, Kihyun Kım, Jeeyun Lee, Hyun Jung Kim, Jung Mi Kwon, Hyo Rak Lee, Young Hye Ko, Suk Joong Oh, Keon Woo Park, Hyo-Jin Kim
SJR Q2Annals of Hematology
Pathology and Forensic MedicineMedicine
4
Article|42 citations·2007
Nongastric marginal zone B‐cell lymphoma: Analysis of 247 cases
Sung Yong Oh, Baek‐Yeol Ryoo, Won Seog Kim, Yeon Hee Park, Kihyun Kım, Hyun Jung Kim, Jung Mi Kwon, Jeeyun Lee, Young Hye Ko, Yong Chan Ahn, Suk Joong Oh, Soon Il Lee
SJR Q1American Journal of Hematology

Nongastric marginal zone B-cell lymphoma (NG-MZL) is a relatively uncommon indolent lymphoma. From 1990 to 2005, a total of 247 patients with histologically confirmed NG-MZL were analyzed. Ann Arbor stage I/II disease was present in 78% (167 out of 215). One hundred eighty-six patients out of two hundred eight were categorized into the low/low-intermediate risk group (89%) according to International Prognostic Index (IPI). Eighty percent (172/215) were in low risk group according to Follicular L

Pathology and Forensic MedicineMedicine
5
letter|39 citations·2006
The effect of pre-irradiation dose intense CHOP on anthracyline resistance in localized nasal NK/T-cell lymphoma.
Se‐Hoon Lee, Yong Chan Ahn, Won Seog Kim, Young H. Ko, Kihyun Kım, Keunchil Park
PubMed

We treated 17 patients with localized, nasal NK/T-cell lymphoma with two cycles of dose-intense CHOP (DI-CHOP) and early involved field radiation (IFRT). Sixteen out of 17 patients were evaluable for response. After two cycles of DICHOP, nine patients achieved complete remission (CR) (53%) and six had partial remissions (35%). After IFRT, 13 patients achieved CR (CR rate 76%; 95% CI, 56%-96%). The 3-year progression-free and overall survival rates were 56%, and 67%, respectively. This study show

Pathology and Forensic MedicineMedicine
6
Article|38 citations·2009
Multidetector CT and MR Imaging of Cardiac Tumors
김은영, 최연현, 성기익, 박승우, 김지혜, 고영혜

The purpose of this article is to provide a current review of the spectrum of multidetector CT (MDCT) and MRI findings for a variety of cardiac neoplasms. In the diagnosis of cardiac tumors, the use of MDCT and MRI can help differentiate benign from malignant masses. Especially, the use of MDCT is advantageous in providing anatomical information and MRI is useful for tissue characterization of cardiac masses. Knowledge of the characteristic MRI findings of benign cardiac tumors or thrombi can be

7
Article|37 citations·2007
Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma
Byeong-Bae Park, Baek‐Yeol Ryoo, Jae Hoon Lee, Hyuck Min Kwon, Sung Hyun Yang, Hye Jin Kang, Hyo J. Kim, Sung Yong Oh, Young H. Ko, Joo Ryung Huh, Seung Lee, Eun Mi Nam
SJR Q2Leukemia & lymphoma/Leukemia and lymphoma

The objective of this retrospective study was to investigate clinical features and treatment outcomes in patients with angioimmunoblastic T-cell lymphoma (AITL), data of which were collected over a 15-year period. Sixty-five patients diagnosed with AITL were included in the study. About half of the patients (46.2%) presented with poor performance status (ECOG > or = 2); 72.3% of patients belonged to high intermediate or high-risk of IPI and same proportion belonged to Class 2 of PIT (Prognostic

OncologyMedicine
8
Article|30 citations·2006
Isolated Blast Crisis in CNS in a Patient With Chronic Myelogenous Leukemia Maintaining Major Cytogenetic Response After Imatinib
Hyun Jung Kim, Chul Won Jung, Kihyun Kım, Jin Seok Ahn, Won Seog Kim, Kwan Park, Young Hye Ko, Won Ki Kang, Keunchil Park
SJR Q1Journal of Clinical OncologyOA

apparently unrelated histiocytic condition, Langerhans histiocytosis with hemophagocytosis, is well-described in this setting. 9 In addition, there are only a few rare case reports describing splenic involvement by SHML, and in these cases there was extranodal involvement of adjacent tissues as well, which was not observed in this case. 10,11 The rapid clinical improvement in our patient after splenectomy suggests that there may be therapeutic benefit from early surgical intervention in this set

HematologyMedicine
9
Article|30 citations·2006
MET Expression in Sporadic Renal Cell Carcinomas
Jong Sun Choi, Mi Kyung Kim, Jin Won Seo, 최윤라, 김동훈, Yi Kyeong Chun, 고영혜
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0191120060210040672

Although germline mutations of met proto-oncogene on human chromosome 7q31-34 have been known as useful molecular markers of hereditary papillary renal cell carcinoma (RCC), the expression of MET, a product of met proto-oncogene, has not been fully studied in sporadic RCC, along with its clinical significance. We inves-tigated the expression of MET by immunohistochemistry in 182 cases of renal neo-plasm encompassing 145 RCC, 25 urothelial carcinomas of renal pelvis, and 12 oncocytomas. MET was d

10
Article|27 citations·2011
WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide Study
김진만, 고영혜, 이승숙, 허주령, 강창석, 김철우, 강윤경, 고재향, 김민경, 김완섭, 김윤정, 김현정
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0357920110450030254

Background: The aim of study was to determine the relative frequency of malignant lymphoma according to World Health Organization (WHO) classification in Korea. Methods: A total of 3,998 cases diagnosed at 31 institutes between 2005 and 2006 were enrolled. Information including age, gender, pathologic diagnosis, site of involvement and immunophenotypes were obtained. Results: The relative frequency of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) was 95.4% and 4.6%, respectively. B-cell l

11
Article|22 citations·2010
Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity
Seok Jin Kim, Kihyun Kım, Yong Park, Byung‐Soo Kim, Jooryung Huh, Young H. Ko, Keunchil Park, Cheolwon Suh, Won Seog Kim
SJR Q1Investigational New Drugs
Pathology and Forensic MedicineMedicine
12
Article|22 citations·2007
HMCO5, herbal extract, inhibits NF-κB expression in lipopolysaccharide treated macrophages and reduces atherosclerotic lesions in cholesterol fed mice
Ki Mo Kim, Jin Yong Choi, Sieun Yoo, Mi Young Park, Bok-Soo Lee, Young Hye Ko, Sang Hyun Sung, Heung‐Mook Shin, Jeong Euy Park
SJR Q1Journal of Ethnopharmacology
SurgeryMedicine
13
Article|18 citations·2007
Nongastric marginal zone B-cell lymphoma: A prognostic model from a retrospective multicenter study
Sung Yong Oh, Hyuk‐Chan Kwon, Won Seog Kim, Winnie Yeo, Kihyun Kım, Hyun Jung Kim, Jung Mi Kwon, Jeeyun Lee, Young Hye Ko, Yong Chan Ahn, Suk Joong Oh, Soon Il Lee
SJR Q1Cancer Letters
Pathology and Forensic MedicineMedicine
14
Article|15 citations·2017
Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a singlecenter experience in Korea
김해수, 김희진, 김선희, 최준영, 고영혜, 김원석, 정철원, 김석진

Background/Aims: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that typically presents in the form of skin manifestations with or without lymph node and bone marrow involvement. Given its rarity and recent recognition as a distinct pathological entity, no standard of treatment exists for this aggressive disease and its prognosis is particularly dismal. Methods: We retrospectively analyzed clinical features and treatment outcomes of patients who were diagno

15
Article|14 citations·2018
Validation of the Marginal Zone Lymphoma International Prognostic Index
Joohyun Hong, Junhun Cho, Young Hye Ko, Seok Jin Kim, Won Seog Kim
SJR Q2Annals of Hematology
Pathology and Forensic MedicineMedicine

Research Areas

Pathology and Forensic MedicineOncologyMolecular BiologyHematologySurgeryDermatology

Young Hye Koの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。